Chad W M Ritenour1, Kristy D Seidel2, Wendy Leisenring3, Ann C Mertens4, Karen Wasilewski-Masker4, Margarett Shnorhavorian5, Charles A Sklar6, John A Whitton2, Marilyn Stovall7, Louis S Constine8, Gregory T Armstrong9, Leslie L Robison9, Lillian R Meacham4. 1. Department of Urology, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: criteno@emory.edu. 2. Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. 3. Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Clinical Statistics Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. 4. The Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA, USA; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. 5. Division of Pediatric Urology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA. 6. Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. 7. Department of Radiation Physics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. 8. Departments of Radiation Oncology and Pediatrics, University of Rochester, Rochester, NY, USA. 9. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA.
Abstract
INTRODUCTION: With survival rates higher than 80%, the number of survivors from pediatric cancer continues to increase. Late effects resulting from cancer and cancer therapy are being characterized, but little information exists on sexual health for men who have survived childhood cancer. AIM: To assess erectile dysfunction (ED) in men who survived childhood and adolescent cancers and to identify potential risk factors for ED. METHODS: In total, 1,622 men and 271 eligible brothers in the Childhood Cancer Survivor Study cohort completed the Male Health Questionnaire, which provided information on sexual practices and sexual function. Combined with demographic, cancer, and treatment information from medical record abstraction, results of the Male Health Questionnaire were analyzed using multivariable modeling. The International Index of Erectile Function was used to identify ED in subjects. MAIN OUTCOME MEASURE: International Index of Erectile Function. RESULTS: Survivors (mean age = 37.4 years, SD = 7.3 years) reported significantly lower sexual activity in the year before the survey than the brothers (mean age = 38.8 years, SD = 8.5 years) without cancer. ED was reported by 12.3% (95% CI = 10.4-14.3) of survivors and 4.2% (95% CI = 2.0-7.9) of brothers. Survivors showed significantly higher relative risk (RR) for ED (RR = 2.63, 95% CI = 1.40-4.97). In addition to older age, survivors who were exposed to higher-dose (≥10 Gy) testicular radiation (RR = 3.55, 95% CI = 1.53-8.24), had surgery on the spinal cord or nerves (RR = 2.87, 95% CI = 1.36-6.05), prostate surgery (RR = 6.56, 95% CI = 3.84-11.20), or pelvic surgery (RR = 2.28, 95% CI = 1.04-4.98) were at higher risk for ED. CONCLUSION: Men who have survived childhood cancer have a greater than 2.6-fold increased risk for ED and certain cancer-specific treatments are associated with increased risk. Attention to sexual health, with its physical and emotional implications, and opportunities for early detection and intervention in these individuals could be important. Published by Elsevier Inc.
INTRODUCTION: With survival rates higher than 80%, the number of survivors from pediatric cancer continues to increase. Late effects resulting from cancer and cancer therapy are being characterized, but little information exists on sexual health for men who have survived childhood cancer. AIM: To assess erectile dysfunction (ED) in men who survived childhood and adolescent cancers and to identify potential risk factors for ED. METHODS: In total, 1,622 men and 271 eligible brothers in the Childhood Cancer Survivor Study cohort completed the Male Health Questionnaire, which provided information on sexual practices and sexual function. Combined with demographic, cancer, and treatment information from medical record abstraction, results of the Male Health Questionnaire were analyzed using multivariable modeling. The International Index of Erectile Function was used to identify ED in subjects. MAIN OUTCOME MEASURE: International Index of Erectile Function. RESULTS: Survivors (mean age = 37.4 years, SD = 7.3 years) reported significantly lower sexual activity in the year before the survey than the brothers (mean age = 38.8 years, SD = 8.5 years) without cancer. ED was reported by 12.3% (95% CI = 10.4-14.3) of survivors and 4.2% (95% CI = 2.0-7.9) of brothers. Survivors showed significantly higher relative risk (RR) for ED (RR = 2.63, 95% CI = 1.40-4.97). In addition to older age, survivors who were exposed to higher-dose (≥10 Gy) testicular radiation (RR = 3.55, 95% CI = 1.53-8.24), had surgery on the spinal cord or nerves (RR = 2.87, 95% CI = 1.36-6.05), prostate surgery (RR = 6.56, 95% CI = 3.84-11.20), or pelvic surgery (RR = 2.28, 95% CI = 1.04-4.98) were at higher risk for ED. CONCLUSION:Men who have survived childhood cancer have a greater than 2.6-fold increased risk for ED and certain cancer-specific treatments are associated with increased risk. Attention to sexual health, with its physical and emotional implications, and opportunities for early detection and intervention in these individuals could be important. Published by Elsevier Inc.
Entities:
Keywords:
Cancer Survivorship; Erectile Dysfunction; Pediatric Cancer; Sexual Dysfunction
Authors: Gregory T Armstrong; Toana Kawashima; Wendy Leisenring; Kayla Stratton; Marilyn Stovall; Melissa M Hudson; Charles A Sklar; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2014-03-17 Impact factor: 44.544
Authors: Andrea M Isidori; Jacques Buvat; Giovanni Corona; Irwin Goldstein; Emmanule A Jannini; Andrea Lenzi; Hartmut Porst; Andrea Salonia; Abdulmaged M Traish; Mario Maggi Journal: Eur Urol Date: 2013-08-29 Impact factor: 20.096
Authors: K Wasilewski-Masker; K D Seidel; W Leisenring; A C Mertens; M Shnorhavorian; C W Ritenour; M Stovall; D M Green; C A Sklar; G T Armstrong; L L Robison; L R Meacham Journal: J Cancer Surviv Date: 2014-04-08 Impact factor: 4.442
Authors: Janet S de Moor; Angela B Mariotto; Carla Parry; Catherine M Alfano; Lynne Padgett; Erin E Kent; Laura Forsythe; Steve Scoppa; Mark Hachey; Julia H Rowland Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-03-27 Impact factor: 4.254
Authors: Sharon L Bober; Eric S Zhou; Bing Chen; Peter E Manley; Lisa B Kenney; Christopher J Recklitis Journal: J Sex Med Date: 2013-05-16 Impact factor: 3.802
Authors: Melissa M Hudson; Kirsten K Ness; James G Gurney; Daniel A Mulrooney; Wassim Chemaitilly; Kevin R Krull; Daniel M Green; Gregory T Armstrong; Kerri A Nottage; Kendra E Jones; Charles A Sklar; Deo Kumar Srivastava; Leslie L Robison Journal: JAMA Date: 2013-06-12 Impact factor: 56.272
Authors: Jennifer N Stinson; Lindsay A Jibb; Mark Greenberg; Maru Barrera; Stephanie Luca; Meghan E White; Abha Gupta Journal: J Adolesc Young Adult Oncol Date: 2015-06 Impact factor: 2.223
Authors: Laura van Iersel; Zhenghong Li; Wassim Chemaitilly; Leslie R Schover; Kirsten K Ness; Melissa M Hudson; James L Klosky Journal: JAMA Oncol Date: 2018-11-01 Impact factor: 31.777
Authors: Tara M Brinkman; Christopher J Recklitis; Gisela Michel; Martha A Grootenhuis; James L Klosky Journal: J Clin Oncol Date: 2018-06-06 Impact factor: 44.544
Authors: Jordan Gilleland Marchak; Kristy D Seidel; Ann C Mertens; Chad W M Ritenour; Karen Wasilewski-Masker; Wendy M Leisenring; Charles A Sklar; Jennifer S Ford; Kevin R Krull; Marilyn Stovall; Leslie L Robison; Gregory T Armstrong; Lillian R Meacham Journal: Cancer Date: 2018-04-17 Impact factor: 6.860
Authors: Natasha N Frederick; Vicky Lehmann; Astrid Ahler; Kristen Carpenter; Brooke Cherven; James L Klosky; Leena Nahata; Gwendolyn P Quinn Journal: Pediatr Blood Cancer Date: 2021-12-06 Impact factor: 3.838
Authors: Brooke Cherven; Amani Sampson; Sharon L Bober; Kristin Bingen; Natasha Frederick; David R Freyer; Gwendolyn P Quinn Journal: CA Cancer J Clin Date: 2020-12-07 Impact factor: 508.702
Authors: Damiano Pizzol; Tao Xiao; Lee Smith; Guillermo F López Sánchez; Andrea Garolla; Christopher Parris; Yvonne Barnett; Petre Cristian Ilie; Pinar Soysal; Jae Il Shin; Mark A Tully; Lin Yang; Nicola Veronese; Igor Grabovac Journal: Br J Gen Pract Date: 2021-04-29 Impact factor: 5.386